ROXYSAF

This brand name is authorized in Nigeria.

Active ingredients

The drug ROXYSAF contains one active pharmaceutical ingredient (API):

1	Roxithromycin UNII 21KOF230FA - ROXITHROMYCIN
	Roxithromycin is a semi-synthetic macrolide antibiotic. Roxithromycin is bacteriostatic at low concentrations and bactericidal at high concentrations. It binds to the 50S subunit of the 70S ribosome, thereby disrupting bacterial protein synthesis.
	Read more about Roxithromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5446	Tablet	ROXYSAF TABLET ROXITHROMYCIN 150mg TAB 150 mg 1 X 10Tablets	46 RNW-PP-170679 ROXYSAF TABLET ROXITHROMYCIN 150mg Roxithromycin 150mg List of Excipients:, Lactose ,starch ,Gelatin ,Primogel ,Magnesium stearate ,Aerosil ,Opadry White ,PEG 6000 ,Purified water B4-5446 Drugs Imported Products 1x10Tablets Prescription Only Medicine (POM) 10/15/2020 NURUSHAT VENTURES LIMITED, FARAMOBI AJIKE STREET ANTHONY VILLAGE ANTHONY VILLAGE LAGOS 12347658 yomee_penners5@yahoo.com SAFFRON PHARMACEUTICALS (PVT) LTD, 19Km, Sheikhupura Road, Faisalabad-Pakistan, Pakistan	27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA06	Roxithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5446